Showing results (381-390 of 427) with videos related to
Sort By:
Pageof 43
Clinical Breast Cancer|October 12, 2015
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast CancerNeil M Iyengar, Monica N Fornier, Steven M Sugarman, et al.Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013Tari A King, Jaclyn P Lyman, Mithat Gonen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004Eric P Winer, Clifford Hudis, Harold J Burstein, et al.Breast Cancer Research and Treatment|November 21, 2016
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)Rachel A Freedman, D K Seisler, J C Foster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumabLee S Schwartzberg, Kurt W Tauer, Robert C Hermann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerMaki Tanioka, Cheng Fan, Joel S Parker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
First-in-Human Trial of Epichaperome-Targeted PET in Patients with CancerMark P S Dunphy, Christina Pressl, Nagavarakishore Pillarsetty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology StatementJennifer A Ligibel, Catherine M Alfano, Dawn Hershman, et al.Cancer Immunology Research|September 3, 2016
Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after ImmunotherapyDavid B Page, Jianda Yuan, David Redmond, et al.Pageof 43